 | • レポートコード：QYR9ST03651 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、帯状疱疹感染治療の世界市場について調査・分析し、帯状疱疹感染治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口、局所、ペアレンタル）、用途別（クリニック、病院、診断センター、在宅ケア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の帯状疱疹感染治療市場動向 ・主要企業別マーケットシェア ・帯状疱疹感染治療の種類別市場規模2014-2019 （経口、局所、ペアレンタル） ・帯状疱疹感染治療の用途別市場規模2014-2019 （クリニック、病院、診断センター、在宅ケア） ・帯状疱疹感染治療の北米市場：主要企業・種類別/用途別市場規模 ・帯状疱疹感染治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・帯状疱疹感染治療の中国市場：主要企業・種類別/用途別市場規模 ・帯状疱疹感染治療の日本国内市場：主要企業・種類別/用途別市場規模 ・帯状疱疹感染治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・帯状疱疹感染治療のインド市場：主要企業・種類別/用途別市場規模 ・帯状疱疹感染治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Valeant Pharmaceuticals、Camber Pharmaceuticals、Novartis、Teva Pharmaceutical、Abbott、Merck） ・帯状疱疹感染治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many years after the occurrence of chicken pox infection and is as reactive as Herpes Zoster.Chickenpox is caused by initial infection of VZV virus, after chicken pox is resolved the virus remains inactive in the nerve cells. The virus gets reactive travels to the nerve end producing blisters. The rash increases within two or three weeks. Herpes zoster appear as blisters on one side of the body usually on neck, face or torso. Some symptoms beyond pain and rashes are fever, headache, fatigue and muscles weakness. Person who had chicken pox is at risk of herpes zoster. The person with the herpes zoster can pass on the virus to someone else who never had chicken pox, but the person will develop chicken pox and not herpes zoster.
Herpes zoster is prevalent in older adults usually between 60 to 80 years as they have weak immune system. People undergoing radiation therapy or chemotherapy weakens the immune system and are more prone to herpes zoster disease. The diagnosis of the herpes zoster is done by laboratory test to detect the VZV antibody in the blood. After the diagnosis of the herpes zoster medication is given for the treatment which include oral medicines, topical and vaccines. Antihistamines, numbing creams, gels, or patches are given to reduce the pain. Vaccines are mostly given to the older people who have a higher risk of getting the herpes zoster
In 2018, the global Herpes Zoster Infection Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Herpes Zoster Infection Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Herpes Zoster Infection Treatment development in United States, Europe and China.
The key players covered in this study
Valeant Pharmaceuticals
Camber Pharmaceuticals
Novartis
Teva Pharmaceutical
Abbott
Merck
…
Market segment by Type, the product can be split into
Oral
Topical
Parental
Market segment by Application, split into
Clinics
Hospitals
Diagnostic centers
Home Care
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Herpes Zoster Infection Treatment status, future forecast, growth opportunity, key market and key players.
To present the Herpes Zoster Infection Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Herpes Zoster Infection Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Topical
1.4.4 Parental
1.5 Market by Application
1.5.1 Global Herpes Zoster Infection Treatment Market Share by Application (2014-2025)
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Diagnostic centers
1.5.5 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Herpes Zoster Infection Treatment Market Size
2.2 Herpes Zoster Infection Treatment Growth Trends by Regions
2.2.1 Herpes Zoster Infection Treatment Market Size by Regions (2014-2025)
2.2.2 Herpes Zoster Infection Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Herpes Zoster Infection Treatment Market Size by Manufacturers
3.1.1 Global Herpes Zoster Infection Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Herpes Zoster Infection Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Herpes Zoster Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Herpes Zoster Infection Treatment Key Players Head office and Area Served
3.3 Key Players Herpes Zoster Infection Treatment Product/Solution/Service
3.4 Date of Enter into Herpes Zoster Infection Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Herpes Zoster Infection Treatment Market Size by Type (2014-2019)
4.2 Global Herpes Zoster Infection Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Herpes Zoster Infection Treatment Market Size (2014-2019)
5.2 Herpes Zoster Infection Treatment Key Players in United States
5.3 United States Herpes Zoster Infection Treatment Market Size by Type
5.4 United States Herpes Zoster Infection Treatment Market Size by Application
6 Europe
6.1 Europe Herpes Zoster Infection Treatment Market Size (2014-2019)
6.2 Herpes Zoster Infection Treatment Key Players in Europe
6.3 Europe Herpes Zoster Infection Treatment Market Size by Type
6.4 Europe Herpes Zoster Infection Treatment Market Size by Application
7 China
7.1 China Herpes Zoster Infection Treatment Market Size (2014-2019)
7.2 Herpes Zoster Infection Treatment Key Players in China
7.3 China Herpes Zoster Infection Treatment Market Size by Type
7.4 China Herpes Zoster Infection Treatment Market Size by Application
8 Japan
8.1 Japan Herpes Zoster Infection Treatment Market Size (2014-2019)
8.2 Herpes Zoster Infection Treatment Key Players in Japan
8.3 Japan Herpes Zoster Infection Treatment Market Size by Type
8.4 Japan Herpes Zoster Infection Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Herpes Zoster Infection Treatment Market Size (2014-2019)
9.2 Herpes Zoster Infection Treatment Key Players in Southeast Asia
9.3 Southeast Asia Herpes Zoster Infection Treatment Market Size by Type
9.4 Southeast Asia Herpes Zoster Infection Treatment Market Size by Application
10 India
10.1 India Herpes Zoster Infection Treatment Market Size (2014-2019)
10.2 Herpes Zoster Infection Treatment Key Players in India
10.3 India Herpes Zoster Infection Treatment Market Size by Type
10.4 India Herpes Zoster Infection Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Herpes Zoster Infection Treatment Market Size (2014-2019)
11.2 Herpes Zoster Infection Treatment Key Players in Central & South America
11.3 Central & South America Herpes Zoster Infection Treatment Market Size by Type
11.4 Central & South America Herpes Zoster Infection Treatment Market Size by Application
12 International Players Profiles
12.1 Valeant Pharmaceuticals
12.1.1 Valeant Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Herpes Zoster Infection Treatment Introduction
12.1.4 Valeant Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2014-2019)
12.1.5 Valeant Pharmaceuticals Recent Development
12.2 Camber Pharmaceuticals
12.2.1 Camber Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Herpes Zoster Infection Treatment Introduction
12.2.4 Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2014-2019)
12.2.5 Camber Pharmaceuticals Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Herpes Zoster Infection Treatment Introduction
12.3.4 Novartis Revenue in Herpes Zoster Infection Treatment Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Teva Pharmaceutical
12.4.1 Teva Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Herpes Zoster Infection Treatment Introduction
12.4.4 Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2014-2019)
12.4.5 Teva Pharmaceutical Recent Development
12.5 Abbott
12.5.1 Abbott Company Details
12.5.2 Company Description and Business Overview
12.5.3 Herpes Zoster Infection Treatment Introduction
12.5.4 Abbott Revenue in Herpes Zoster Infection Treatment Business (2014-2019)
12.5.5 Abbott Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Herpes Zoster Infection Treatment Introduction
12.6.4 Merck Revenue in Herpes Zoster Infection Treatment Business (2014-2019)
12.6.5 Merck Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Herpes Zoster Infection Treatment Key Market Segments
Table Key Players Herpes Zoster Infection Treatment Covered
Table Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Herpes Zoster Infection Treatment Market Size Market Share by Type 2014-2025
Figure Oral Figures
Table Key Players of Oral
Figure Topical Figures
Table Key Players of Topical
Figure Parental Figures
Table Key Players of Parental
Table Global Herpes Zoster Infection Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinics Case Studies
Figure Hospitals Case Studies
Figure Diagnostic centers Case Studies
Figure Home Care Case Studies
Figure Herpes Zoster Infection Treatment Report Years Considered
Table Global Herpes Zoster Infection Treatment Market Size 2014-2025 (Million US$)
Figure Global Herpes Zoster Infection Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Herpes Zoster Infection Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Herpes Zoster Infection Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Herpes Zoster Infection Treatment Market Share by Regions 2014-2019
Figure Global Herpes Zoster Infection Treatment Market Share by Regions 2014-2019
Figure Global Herpes Zoster Infection Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Herpes Zoster Infection Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Herpes Zoster Infection Treatment Market Share by Manufacturers (2014-2019)
Figure Global Herpes Zoster Infection Treatment Market Share by Manufacturers in 2018
Table Global Herpes Zoster Infection Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Herpes Zoster Infection Treatment Product/Solution/Service
Table Date of Enter into Herpes Zoster Infection Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Herpes Zoster Infection Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Herpes Zoster Infection Treatment Market Size Share by Type (2014-2019)
Figure Global Herpes Zoster Infection Treatment Market Size Market Share by Type (2014-2019)
Table Global Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Herpes Zoster Infection Treatment Market Size Share by Application (2014-2019)
Figure Global Herpes Zoster Infection Treatment Market Size Market Share by Application (2014-2019)
Figure Global Herpes Zoster Infection Treatment Revenue Market Share by Application in 2018
Figure United States Herpes Zoster Infection Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Herpes Zoster Infection Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Herpes Zoster Infection Treatment Market Share (2018-2019)
Table United States Herpes Zoster Infection Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Herpes Zoster Infection Treatment Market Share by Type (2014-2019)
Table United States Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Herpes Zoster Infection Treatment Market Share by Application (2014-2019)
Figure Europe Herpes Zoster Infection Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Herpes Zoster Infection Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Herpes Zoster Infection Treatment Market Share (2018-2019)
Table Europe Herpes Zoster Infection Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Herpes Zoster Infection Treatment Market Share by Type (2014-2019)
Table Europe Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Herpes Zoster Infection Treatment Market Share by Application (2014-2019)
Figure China Herpes Zoster Infection Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Herpes Zoster Infection Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Herpes Zoster Infection Treatment Market Share (2018-2019)
Table China Herpes Zoster Infection Treatment Market Size by Type (2014-20189) (Million US$)
Table China Herpes Zoster Infection Treatment Market Share by Type (2014-2019)
Table China Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table China Herpes Zoster Infection Treatment Market Share by Application (2014-2019)
Figure Japan Herpes Zoster Infection Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Herpes Zoster Infection Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Herpes Zoster Infection Treatment Market Share (2018-2019)
Table Japan Herpes Zoster Infection Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Herpes Zoster Infection Treatment Market Share by Type (2014-2019)
Table Japan Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Herpes Zoster Infection Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Herpes Zoster Infection Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Herpes Zoster Infection Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Herpes Zoster Infection Treatment Market Share (2018-2019)
Table Southeast Asia Herpes Zoster Infection Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Herpes Zoster Infection Treatment Market Share by Type (2014-2019)
Table Southeast Asia Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Herpes Zoster Infection Treatment Market Share by Application (2014-2019)
Figure India Herpes Zoster Infection Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Herpes Zoster Infection Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Herpes Zoster Infection Treatment Market Share (2018-2019)
Table India Herpes Zoster Infection Treatment Market Size by Type (2014-2019) (Million US$)
Table India Herpes Zoster Infection Treatment Market Share by Type (2014-2019)
Table India Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table India Herpes Zoster Infection Treatment Market Share by Application (2014-2019)
Figure Central & South America Herpes Zoster Infection Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Herpes Zoster Infection Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Herpes Zoster Infection Treatment Market Share (2018-2019)
Table Central & South America Herpes Zoster Infection Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Herpes Zoster Infection Treatment Market Share by Type (2014-2019)
Table Central & South America Herpes Zoster Infection Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Herpes Zoster Infection Treatment Market Share by Application (2014-2019)
Table Valeant Pharmaceuticals Company Details
Table Valeant Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2014-2019) (Million US$)
Figure Valeant Pharmaceuticals Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2014-2019)
Table Valeant Pharmaceuticals Recent Development
Table Camber Pharmaceuticals Company Details
Table Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2014-2019)(Million US$)
Figure Camber Pharmaceuticals Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2014-2019)
Table Camber Pharmaceuticals Recent Development
Table Novartis Company Details
Table Novartis Revenue in Herpes Zoster Infection Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2014-2019)
Table Novartis Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Abbott Company Details
Table Abbott Revenue in Herpes Zoster Infection Treatment Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2014-2019)
Table Abbott Recent Development
Table Merck Company Details
Table Merck Revenue in Herpes Zoster Infection Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Herpes Zoster Infection Treatment Business (2014-2019)
Table Merck Recent Development
Table Global Herpes Zoster Infection Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Herpes Zoster Infection Treatment Market Size Share by Regions (2019-2025)
Figure Global Herpes Zoster Infection Treatment Market Size Share by Regions in 2025
Figure United States Herpes Zoster Infection Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Herpes Zoster Infection Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Herpes Zoster Infection Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Herpes Zoster Infection Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Herpes Zoster Infection Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Herpes Zoster Infection Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Herpes Zoster Infection Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Herpes Zoster Infection Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Herpes Zoster Infection Treatment Market Size by Product (2019-2025)
Figure Global Herpes Zoster Infection Treatment Market Size by Product in 2025
Table Global Herpes Zoster Infection Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Herpes Zoster Infection Treatment Market Size by Application (2019-2025)
Figure Global Herpes Zoster Infection Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
単純ヘルペスウイルス治療の世界市場：市場規模・現状・予測 The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbrea…- 性器ヘルペス治療薬の世界市場：市場規模・現状・予測 Genital herpes is a sexually transmitted disease (STD). This STD causes herpetic sores, which are painful blisters (fluid-filled bumps) that can break open and ooze fluid. About 16 percentTrusted Source of people between the ages of 14 and 49 have this STD.In 2018, the global Genital Herpes Treatmen…
- 耳感染治療の世界市場：市場規模・現状・予測 An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…
- 尿路感染症治療の世界市場：市場規模・現状・予測 Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland.This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasing…
- 尿路感染症治療の世界市場：市場規模・現状・予測 Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland.This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasing…